H.C. Wainwright Maintains ATAI Life Sciences(ATAI.US) With Buy Rating, Maintains Target Price $10
H.C. Wainwright Remains a Buy on ATAI Life Sciences (ATAI)
H.C. Wainwright Maintains ATAI Life Sciences(ATAI.US) With Buy Rating, Maintains Target Price $10
H.C. Wainwright Maintains ATAI Life Sciences(ATAI.US) With Buy Rating, Maintains Target Price $10
HC Wainwright & Co. Reiterates Buy on ATAI Life Sciences, Maintains $10 Price Target
ATAI Life Sciences Analyst Ratings
TD Cowen Maintains ATAI Life Sciences(ATAI.US) With Buy Rating
ATAI Life Sciences Analyst Ratings
H.C. Wainwright Maintains ATAI Life Sciences(ATAI.US) With Buy Rating, Maintains Target Price $10
H.C. Wainwright Maintains ATAI Life Sciences(ATAI.US) With Buy Rating, Maintains Target Price $10
TD Cowen Maintains ATAI Life Sciences(ATAI.US) With Buy Rating
H.C. Wainwright Maintains ATAI Life Sciences(ATAI.US) With Buy Rating, Maintains Target Price $10
ATAI Life Sciences Analyst Ratings
H.C. Wainwright Maintains ATAI Life Sciences(ATAI.US) With Buy Rating, Maintains Target Price $10
HC Wainwright & Co. Maintains Buy on ATAI Life Sciences, Lowers Price Target to $10
ATAI Life Sciences Price Target Maintained With a $11.00/Share by Canaccord Genuity
ATAI Life Sciences Analyst Ratings
Maxim Group Maintains ATAI Life Sciences(ATAI.US) With Buy Rating, Maintains Target Price $6
TD Cowen Maintains ATAI Life Sciences(ATAI.US) With Buy Rating
TD Cowen Maintains ATAI Life Sciences(ATAI.US) With Buy Rating